Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v3.22.4
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Class A
Common Stock
Common Class A
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Beginning balance (in shares) at Dec. 26, 2019     101,458,000      
Beginning balance at Dec. 26, 2019 $ 764,336   $ 101 $ 370,413 $ (193) $ 394,015
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 16,115     16,115    
Exercise of stock options (in shares)     2,485,000      
Exercise of stock options 19,254   $ 2 19,252    
Issuance of restricted stock award (in shares)     369,000      
Issuance of restricted stock awards $ 1   $ 1      
Shares issued under employee stock purchase plan (in shares) 56,389   56,000      
Shares issued under employee stock purchase plan $ 2,344     2,344    
Other comprehensive gain, net of tax 357       357  
Net income 194,981         194,981
Ending balance (in shares) at Dec. 31, 2020     104,368,000      
Ending balance at Dec. 31, 2020 997,388   $ 104 408,124 164 588,996
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 20,528     20,528    
Exercise of stock options (in shares)     1,253,000      
Exercise of stock options 14,736   $ 2 14,734    
Issuance of restricted stock award (in shares)     29,000      
Issuance of restricted stock awards $ 0   $ 0      
Forfeiture of restricted stock awards (in shares)     (3,000)      
Issuance of common stock upon vesting of restricted stock units (in shares)     29,000      
Shares issued under employee stock purchase plan (in shares) 46,273   46,000      
Shares issued under employee stock purchase plan $ 3,063     3,063    
Issuance of stock related to acquisition (in shares)     50,000      
Issuance of stock related to acquisition 5,000     5,000    
Common stock redeemed for tax liability (in shares)     (11,000)      
Common stock redeemed for tax liability (1,117)     (1,117)    
Other comprehensive gain, net of tax 371       371  
Net income 283,230         283,230
Ending balance (in shares) at Dec. 30, 2021   105,760,650 105,761,000      
Ending balance at Dec. 30, 2021 1,323,199   $ 106 450,332 535 872,226
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense $ 22,233     22,233    
Exercise of stock options (in shares) 352,455   352,000      
Exercise of stock options $ 7,592     7,592    
Forfeiture of restricted stock awards (in shares)     (59,000)      
Issuance of common stock upon vesting of restricted stock units (in shares)     59,000      
Shares issued under employee stock purchase plan (in shares) 62,274   62,000      
Shares issued under employee stock purchase plan $ 4,379     4,379    
Common stock redeemed for tax liability (in shares)     (24,000)      
Common stock redeemed for tax liability (2,224)     (2,224)    
Other comprehensive gain, net of tax 3,802       3,802  
Net income 298,195         298,195
Ending balance (in shares) at Dec. 29, 2022   106,150,661 106,151,000      
Ending balance at Dec. 29, 2022 $ 1,657,176   $ 106 $ 482,312 $ 4,337 $ 1,170,421